• 1
    Kriegmair M, Baumgartner R, Knuchel R, Stepp H, Hofstadter F, Hofstetter A. Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. J Urol 1996; 155: 1059
  • 2
    Lange N, Jichlinski P, Zellweger M et al. Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study. Br J Cancer 1999; 80: 18593
  • 3
    Karl A, Tritschler S, Stanislaus P et al. Positive urine cytology but negative white-light cystoscopy: an indication for fluorescence cystoscopy? BJU Int 2009; 103: 4847
  • 4
    Burger M, Stief CG, Zaak D et al. Hexaminolevulinate is equal to 5-aminolevulinic acid concerning residual tumor and recurrence rate following photodynamic diagnostic assisted transurethral resection of bladder tumors. Urology 2009; 74: 12826
  • 5
    Stenzl A, Burger M, Fradet Y et al. Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer. J Urol 2010; 184: 190713
  • 6
    Stenzl A, Penkoff H, Dajc-Sommerer E et al. Detection and clinical outcome of urinary bladder cancer with 5-aminolevulinic acid-induced fluorescence cystoscopy: a multicenter randomized, double-blind, placebo-controlled trial. Cancer 2011; 117: 93847
  • 7
    Schumacher MC, Holmang S, Davidsson T, Friedrich B, Pedersen J, Wiklund NP. Transurethral resection of non-muscle-invasive bladder transitional cell cancers with or without 5-aminolevulinic Acid under visible and fluorescent light: results of a prospective, randomised, multicentre study. Eur Urol 2010; 57: 2939
  • 8
    Mowatt G, Zhu S, Kilonzo M et al. Systematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer. Health Technol Assess 2010; 14: 1331, iii-iv
  • 9
    Witjes JA, Redorta JP, Jacqmin D et al. Hexaminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: review of the evidence and recommendations. Eur Urol 2010; 57: 60714
  • 10
    Patel P, Bryan RT, Wallace DM. Emerging endoscopic and photodynamic techniques for bladder cancer detection and surveillance. ScientificWorldJournal 2011; 11: 25508
  • 11
    Tekade RK, Kumar PV, Jain NK. Dendrimers in oncology: an expanding horizon. Chem Rev 2009; 109: 4987
  • 12
    Battah S, Balaratnam S, Casas A et al. Macromolecular delivery of 5-aminolaevulinic acid for photodynamic therapy using dendrimer conjugates. Mol Cancer Ther 2007; 6: 87685
  • 13
    Casas A, Battah S, Di Venosa G et al. Sustained and efficient porphyrin generation in vivo using dendrimer conjugates of 5-ALA for photodynamic therapy. J Control Release 2009; 135: 13643
  • 14
    Perotti C, Fukuda H, DiVenosa G, MacRobert AJ, Batlle A, Casas A. Porphyrin synthesis from ALA derivatives for photodynamic therapy. In vitro and in vivo studies. Br J Cancer 2004; 90: 16605
  • 15
    Di Venosa G, Fukuda H, Perotti C, Batlle A, Casas A. A method for separating ALA from ALA derivatives using ionic exchange extraction. J Photochem Photobiol B 2004; 75: 15763
  • 16
    Xiao Z, McCallum TJ, Brown KM et al. Characterization of a novel transplantable orthotopic rat bladder transitional cell tumour model. Br J Cancer 1999; 81: 63846
  • 17
    Collaud S, Jichlinski P, Marti A, Aymon D, Gurny R, Lange N. An open pharmacokinetic study of hexylaminolevulinate-induced photodiagnosis after intravesical administration. Drugs R D 2006; 7: 17386
  • 18
    Cosserat-Gerardin I, Bezdetnaya L, Notter D, Vigneron C, Guillemin F. Biosynthesis and photodynamic efficacy of protoporphyrin IX (PpIX) generated by 5-aminolevulinic acid (ALA) or its hexylester (hALA) in rat bladder carcinoma cells. J Photochem Photobiol B 2000; 59: 729
  • 19
    El Khatib S, Didelon J, Leroux A, Bezdetnaya L, Notter D, D'Hallewin M. Kinetics, biodistribution and therapeutic efficacy of hexylester 5-aminolevulinate induced photodynamic therapy in an orthotopic rat bladder tumor model. J Urol 2004; 172: 20137
  • 20
    Malik N, Wiwattanapatapee R, Klopsch R et al. Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo. J Control Release 2000; 65: 13348
  • 21
    Heil P, Stocker S, Sroka R, Baumgartner R. In vivo fluorescence kinetics of porphyrins following intravesical instillation of 5-aminolaevulinic acid in normal and tumour-bearing rat bladders. J Photochem Photobiol B 1997; 38: 15863
  • 22
    Hainau B. Luminal plasma membrane organization in rat urinary bladder urothelium after direct exposure in vivo to N-methyl-N-nitrosourea. Cancer Res 1979; 39: 375762
  • 23
    Hicks RM, Wakefield JJ. Membrane changes during urothelial hyperplasia and neoplasia. Cancer Res 1976; 36: 25027
  • 24
    Marti A, Jichlinski P, Lange N et al. Comparison of aminolevulinic acid and hexylester aminolevulinate induced protoporphyrin IX distribution in human bladder cancer. J Urol 2003; 170: 42832
  • 25
    Menjoge AR, Navath RS, Asad A et al. Transport and biodistribution of dendrimers across human fetal membranes: implications for intravaginal administration of dendrimer-drug conjugates. Biomaterials 2010; 31: 500721
  • 26
    Battah S, O'Neill S, Edwards C, Balaratnam S, Dobbin P, MacRobert AJ. Enhanced porphyrin accumulation using dendritic derivatives of 5-aminolaevulinic acid for photodynamic therapy: an in vitro study. Int J Biochem Cell Biol 2006; 38: 138292
  • 27
    Di Venosa G, Fukuda H, Batlle A, Macrobert A, Casas A. Photodynamic therapy: regulation of porphyrin synthesis and hydrolysis from ALA esters. J Photochem Photobiol B 2006; 83: 12936
  • 28
    Berrahmoune S, Fotinos N, Bezdetnaya L et al. Analysis of differential PDT effect in rat bladder tumor models according to concentrations of intravesical hexyl-aminolevulinate. Photochem Photobiol Sci 2008; 7: 101824
  • 29
    Mackenzie GD, Dunn JM, Selvasekar CR et al. Optimal conditions for successful ablation of high-grade dysplasia in Barrett's oesophagus using aminolaevulinic acid photodynamic therapy. Lasers Med Sci 2009; 24: 72934
  • 30
    D'Hallewin MA, Vanherzeele H, Baert L. Fluorescence detection of flat transitional cell carcinoma after intravesical instillation of aminolevulinic acid. Am J Clin Oncol 1998; 21: 2235
  • 31
    Hartmann A, Moser K, Kriegmair M, Hofstetter A, Hofstaedter F, Knuechel R. Frequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma. Am J Pathol 1999; 154: 7217